Article
Prognostic impact of clinico-genetic characteristics and donor types in NPM1-mutated AML undergoing allogeneic hematopoietic stem cell transplantation.
Cell transplantation - 1 Jan 2026
Yuan Xiaolin, Wu Yibo, Yang Tingting, Zhu Panpan, Lai Xiaoyu, Liu Lizhen, Yang Luxin, Shi Jimin, Yu Jian, Zhao Yanmin, Zheng Weiyan, Sun Jie, Wu Wenjun, Zhao Yi, Cai Zhen, Huang He, Pei Shanshan, Luo Yi
Abstract excerpt
NPM1-mutated acute myeloid leukemia (AML) is a distinct entity with specific biological and clinicopathological features. Prognosis varies depending on the associated mutations and clinical characteristics. This study evaluated the prognostic factors of NPM1-mutated AML in patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT). We enrolled 139 patients with NPM1-mutated AML who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
